Related Experiment Video
Updated: Jan 12, 2026

In Vivo Two-Color 2-Photon Imaging of Genetically-Tagged Reporter Cells in the Skin
Published on: July 11, 2019
Decoding Fibromyalgia: Genetic Insights into Gut and Immune System Interactions
Mengqi Niu1,2, Jing Li1,2, Victoria Sarafian3,4
1Sichuan Provincial Center for Mental Health, Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, 610072, People's Republic of China.
Certain gut bacteria and inflammatory proteins influence fibromyalgia risk. Some microbes like Ruminococcus gauvreauii increase risk, while others are protective. Inflammatory proteins also show protective or risk associations with fibromyalgia.
Area of Science:
- Genetics
- Microbiology
- Immunology
Background:
- Fibromyalgia (FM) is a chronic condition marked by widespread pain and immune system dysregulation.
- Emerging research indicates gut microbiota and inflammatory proteins may play roles in FM development.
Purpose of the Study:
- To investigate causal links between gut microbiota, inflammatory proteins (cytokines/chemokines), and FM.
- Utilized bidirectional Mendelian randomization (MR) and meta-analysis.
Main Methods:
- Employed MR analyses on European genetic data using MR-IVW, MR-Egger, and MR-weighted median methods.
- Conducted reverse MR with FM as the exposure.
- Performed a meta-analysis to synthesize findings.
Main Results:
- Identified *Ruminococcus gauvreauii* as a risk factor for FM; *Enterorhabdus, Parabacteroides, Butyricicoccus*, and *Prevotella 9* showed protective effects.
- Five inflammatory proteins (CXCL5, S100-A12, LIFR, MCP-2/CCL8, TNF-α) were protective.
- NKCR-2B4/CD244 and IL-12β were associated with increased FM risk.
Conclusions:
- Gut microbiota and inflammatory proteins are implicated in FM pathogenesis.
- Functional analyses suggest involvement in immune regulation, inflammation, and viral pathways.
- Findings offer potential therapeutic targets for FM management through gut health and immune modulation.
Related Concept Videos
Irritable Bowel Syndrome I: Introduction
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Autoimmune Disorders
Concept and Mechanism of Autoimmune Diseases
The immune...
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...

